|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61K 31/454 | |||
| A61K 31/473 | |||
| A61K 31/69 | |||
| A61K 38/05 | |||
| A61P 35/00 | |||
| G01N 33/574 |
| (11) | Number of the document | 3266452 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17168706.4 |
| Date of filing the European patent application | 2012-03-08 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161452027 P | 2011-03-11 | US |
| (72) |
STEWART, Alexander Keith, US
BERGSAGEL, Peter, US
FONSECA, Rafael, US
BRAGGIO, Esteban, US
|
| (73) |
Mayo Foundation for Medical Education and Research,
200 First Street S.W., Rochester, MN 55905,
US
|
| (54) | MEANS TO TREAT MYELOMAS WHICH ARE RESISTANT TO THALIDOMIDE, LENALIDOMIDE OR POMALIDOMIDE |
| MEANS TO TREAT MYELOMAS WHICH ARE RESISTANT TO THALIDOMIDE, LENALIDOMIDE OR POMALIDOMIDE |